Article
Enhanced Antidiabetic Action through Multi-Target Therapy: A Comparative Study of Voglibose-Based Combinations
2025-07-08
Abstract excerpt
<title>Abstract</title> <p>Background Type 2 Diabetes Mellitus (T2DM) is a progressive metabolic disorder marked by insulin resistance and chronic hyperglycemia. Although voglibose, an alpha-glucosidase inhibitor, is used in T2DM management, its efficacy is limited, particularly when used alone. This study aimed to investigate whether combining voglibose with ubiquinone and tempol—agents known for their antioxid...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 6558b02f-aeb1-5d05-8824-35524732b4f5
- DOI
- 10.21203/rs.3.rs-6782451/v1
